A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?
KD Sjauw, AE Engström, MM Vis… - European heart …, 2009 - academic.oup.com
Aims Intra-aortic balloon counterpulsation (IABP) in ST-segment elevation myocardial
infarction (STEMI) with cardiogenic shock is strongly recommended (class IB) in the current …
infarction (STEMI) with cardiogenic shock is strongly recommended (class IB) in the current …
Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee …
MJ Kern, A Lerman, JW Bech, B De Bruyne… - Circulation, 2006 - Am Heart Assoc
With advances in technology, the physiological assessment of coronary artery disease in
patients in the catheterization laboratory has become increasingly important in both clinical …
patients in the catheterization laboratory has become increasingly important in both clinical …
Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease
N Van Royen, JJ Piek, I Buschmann… - Cardiovascular …, 2001 - academic.oup.com
After birth two forms of vessel growth can be observed; angiogenesis and arteriogenesis.
Angiogenesis refers to the formation of capillary networks. Arteriogenesis refers to the …
Angiogenesis refers to the formation of capillary networks. Arteriogenesis refers to the …
Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European …
Developed with the Special Contribution of … - European heart …, 2010 - academic.oup.com
Some surveys have shown that the intended users are sometimes unaware of the existence
of guidelines, or simply do not translate them into practice. Thus, implementation …
of guidelines, or simply do not translate them into practice. Thus, implementation …
Myocardial infarction accelerates atherosclerosis
P Dutta, G Courties, Y Wei, F Leuschner, R Gorbatov… - Nature, 2012 - nature.com
During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaques in the
arterial wall and cause their rupture, thus triggering myocardial infarction and stroke …
arterial wall and cause their rupture, thus triggering myocardial infarction and stroke …
[HTML][HTML] Use of the instantaneous wave-free ratio or fractional flow reserve in PCI
Background Coronary revascularization guided by fractional flow reserve (FFR) is
associated with better patient outcomes after the procedure than revascularization guided by …
associated with better patient outcomes after the procedure than revascularization guided by …
[HTML][HTML] PCI strategies in patients with acute myocardial infarction and cardiogenic shock
Background In patients who have acute myocardial infarction with cardiogenic shock, early
revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) …
revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) …
Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction
DM Ouweneel, E Eriksen, KD Sjauw… - Journal of the American …, 2017 - jacc.org
Background: Despite advances in treatment, mortality in acute myocardial infarction (AMI)
complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory …
complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory …
[HTML][HTML] Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium
L Timmers, SK Lim, F Arslan, JS Armstrong, IE Hoefer… - Stem cell …, 2008 - Elsevier
Although paracrine effects of mesenchymal stem cells (MSCs) have been suggested
previously, cardioprotection by human MSC secretions has never been demonstrated …
previously, cardioprotection by human MSC secretions has never been demonstrated …
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 …
PW Serruys, B Chevalier, Y Sotomi, A Cequier… - The Lancet, 2016 - thelancet.com
Background No medium-term data are available on the random comparison between
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …